Journal of Cancer Research and Therapeutics

ORIGINAL ARTICLE
Year
: 2017  |  Volume : 13  |  Issue : 2  |  Page : 304--312

Dosimetric characterization of optically stimulated luminescence dosimeter with therapeutic photon beams for use in clinical radiotherapy measurements


Retna Ponmalar1, Ravikumar Manickam2, KM Ganesh2, Sathiyan Saminathan2, Arun Raman2, Henry Finlay Godson1 
1 Department of Radiation Physics, Kidwai Memorial Institute of Oncology, Bengaluru, Karnataka; Department of Radiotherapy, Christian Medical College, Vellore, Tamil Nadu, India
2 Department of Radiation Physics, Kidwai Memorial Institute of Oncology, Bengaluru, Karnataka, India

Correspondence Address:
Ravikumar Manickam
Department of Radiation Physics, Kidwai Memorial Institute of Oncology, Dr. M.H. Marigowda Road, Bengaluru - 560 029, Karnataka
India

Aim: The modern radiotherapy techniques impose new challenges for dosimetry systems with high precision and accuracy in in vivo and in phantom dosimetric measurements. The knowledge of the basic characterization of a dosimetric system before patient dose verification is crucial. This incites the investigation of the potential use of nanoDot optically stimulated luminescence dosimeter (OSLD) for application in radiotherapy with therapeutic photon beams. Materials and Methods: Measurements were carried out with nanoDot OSLDs to evaluate the dosimetric characteristics such as dose linearity, dependency on field size, dose rate, energy and source-to-surface distance (SSD), reproducibility, fading effect, reader stability, and signal depletion per read out with cobalt-60 (60 Co) beam, 6 and 18 MV therapeutic photon beams. The data acquired with OSLDs were validated with ionization chamber data where applicable. Results: Good dose linearity was observed for doses up to 300 cGy and above which supralinear behavior. The standard uncertainty with field size observed was 1.10% ± 0.4%, 1.09% ± 0.34%, and 1.2% ± 0.26% for 6 MV, 18 MV, and 60 Co beam, respectively. The maximum difference with dose rate was 1.3% ± 0.4% for 6 MV and 1.4% ± 0.4% for 18 MV photon beams. The largest variation in SSD was 1.5% ± 1.2% for 60 Co, 1.5% ± 0.9% for 6 MV, and 1.5% ± 1.3% for 18 MV photon beams. The energy dependence of OSL response at 18 MV and 60 Co with 6 MV beam was 1.5% ± 0.7% and 1.7% ± 0.6%, respectively. In addition, good reproducibility, stability after the decay of transient signal, and predictable fading were observed. Conclusion: The results obtained in this study indicate the efficacy and suitability of nanoDot OSLD for dosimetric measurements in clinical radiotherapy.


How to cite this article:
Ponmalar R, Manickam R, Ganesh K M, Saminathan S, Raman A, Godson HF. Dosimetric characterization of optically stimulated luminescence dosimeter with therapeutic photon beams for use in clinical radiotherapy measurements.J Can Res Ther 2017;13:304-312


How to cite this URL:
Ponmalar R, Manickam R, Ganesh K M, Saminathan S, Raman A, Godson HF. Dosimetric characterization of optically stimulated luminescence dosimeter with therapeutic photon beams for use in clinical radiotherapy measurements. J Can Res Ther [serial online] 2017 [cited 2022 Oct 7 ];13:304-312
Available from: https://www.cancerjournal.net/article.asp?issn=0973-1482;year=2017;volume=13;issue=2;spage=304;epage=312;aulast=Ponmalar;type=0